跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞复美 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lenalidomide Capsules
Approved
化学药品
Lenalidomide Capsules
Bristol-Myers Squibb Pharma EEIG
🇨🇳 National Medical Products Administration
Approval Date
Dec 7, 2023
Approval ID
8889waV7uC7
Company
Bristol-Myers Squibb Pharma EEIG
Type
化学药品
Approval Details
Approval Id
8889waV7uC7
Approval Number
国药准字HJ20200046
Generic Name
来那度胺胶囊
Generic Name En
Lenalidomide Capsules
Trade Name
瑞复美
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
10mg
Reg Date
2023-12-07
Expired Date
2028-12-06
Company Name
Bristol-Myers Squibb Pharma EEIG
Production Company Name
Celgene International SARL
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Production Company Detail Path
/organization/celgene-international-sarl-belgium
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 7, 2023
Approval ID
8889waV7uC7
Type
化学药品
Back to NMPA Approvals